Invivyd, Inc. (IVVD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00534A1025
Invivyd, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 53.43 m USD |
| Operating income | -55.56 m USD |
| EBIT | -52.49 m USD |
| Net income | -52.49 m USD |
| Diluted EPS – continuing operations | -0.30 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Invivyd, Inc.
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
More stocks
- Robot Consulting Co., Ltd. ADS (LAWR)
- Comstock Holding Companies, Inc. (CHCI)
- White River Bancshares Co (WRIV)
- FRANKLIN COVEY CO (FC)
- Mediwound Ltd (MDWD)
- OMS Energy Technologies Inc. (OMSE)
- Genomictree Inc. (228760.KQ)
- Formosa Optical Technology Co Ltd (5312.TWO)
- RED ROBIN GOURMET BURGERS INC (RRGB)
- 1 800 FLOWERS COM INC (FLWS)
- Anbio Biotechnology Class A Ordinary Shares (NNNN)
- Betmakers Technology Group Ltd (BET.AX)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.